{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T11:52:49Z","timestamp":1768564369597,"version":"3.49.0"},"posted":{"date-parts":[[2023,2,16]]},"group-title":"Infectious Diseases (except HIV\/AIDS)","reference-count":40,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,2,16]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Post-COVID conditions (PCC) are common and have significant morbidity. Risk factors for PCC include advancing age, female sex, obesity, and diabetes mellitus. Little is known about early treatment, inflammation, and PCC.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Among 883 individuals with confirmed SARS-CoV-2 infection participating in a randomized trial of CCP vs. control plasma with available biospecimens and symptom data, the association between early COVID treatment, cytokine levels and PCC was evaluated. Cytokine and chemokine levels were assessed at baseline, day 14 and day 90 using a multiplexed sandwich immuosassay (Mesoscale Discovery). Presence of any self-reported PCC symptoms was assessed at day 90. Associations between COVID treatment, cytokine levels and PCC were examined using multivariate logistic regression models.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>\n                    One-third of the 882 participants had day 90 PCC symptoms, with fatigue (14.5%) and loss of smell (14.5%) being most common. Cytokine levels decreased from baseline to day 90. In a multivariable analysis including diabetes, body mass index, race, and vaccine status, female sex (adjusted odds ratio[AOR]=2.70[1.93-3.81]), older age (AOR=1.32[1.17-1.50]), and elevated baseline levels of IL-6 (AOR=1.59[1.02-2.47]) were associated with development of PCC. There was a trend for decreased PCC in those with early CCP treatment (\n                    <jats:underline>&lt;<\/jats:underline>\n                    5 days after symptom onset) compared to late CCP treatment.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Increased IL-6 levels were associated with the development of PCC and there was a trend for decreased PCC with early CCP treatment in this predominately unvaccinated population. Future treatment studies should evaluate the effect of early treatment and anti-IL-6 therapies on PCC development.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Summary<\/jats:title>\n                  <jats:p>Increased IL-6 levels were associated with the development of Post-COVID Conditions (PCC) and there was a trend for decreased PCC with early COVID convalescent plasma treatment in this predominately unvaccinated population.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2023.02.13.23285855","type":"posted-content","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T15:35:13Z","timestamp":1676561713000},"source":"Crossref","is-referenced-by-count":1,"title":["Early Treatment, Inflammation and Post-COVID Conditions"],"prefix":"10.64898","author":[{"given":"Kelly A.","family":"Gebo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonya L.","family":"Heath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuriko","family":"Fukuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheriza","family":"Baksh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison G.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feben","family":"Habtehyimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Shade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Ruff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malathi","family":"Ram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Laeyendecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinaldo E.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eshan U.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owen R.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shmuel","family":"Shoham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward R.","family":"Cachay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith S.","family":"Currier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan M.","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry","family":"Meisenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald N.","family":"Forthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura L.","family":"Hammitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moises A.","family":"Huaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giselle S.","family":"Mosnaim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bela","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James H.","family":"Paxton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay S.","family":"Raval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine G.","family":"Sutcliffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shweta","family":"Anjan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Gniadek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seble","family":"Kassaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janis E.","family":"Blair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Lane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nichol A.","family":"McBee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy L.","family":"Gawad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piyali","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabra L.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Pekosz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo","family":"Casadevall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan M.","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron A.R.","family":"Tobian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2023021811200605000_2023.02.13.23285855v1.1","unstructured":"Centers for Disease Control and Prevention. COVID Data Tracker. Available at: https:\/\/covid.cdc.gov\/covid-data-tracker\/#datatracker-home. Accessed 11 February 2023."},{"key":"2023021811200605000_2023.02.13.23285855v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00703-9\/ATTACHMENT\/31179DEC-CF64-455B-BD13-6EF0045B7DD6\/MMC1.PDF"},{"key":"2023021811200605000_2023.02.13.23285855v1.3","unstructured":"Centers for Disease Control and Prevention. Long COVID or Post-COVID Conditions. Available at: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/long-term-effects. Accessed 11 February 2023."},{"key":"2023021811200605000_2023.02.13.23285855v1.4","unstructured":"Centers for Disease Control and Prevention. Post-COVID Conditions: Overview for Healthcare Providers. Available at: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/clinical-care\/post-covid-conditions.html. Accessed 11 February 2023."},{"key":"2023021811200605000_2023.02.13.23285855v1.5","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.28568"},{"key":"2023021811200605000_2023.02.13.23285855v1.6","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control and Prevention. Post\u2013COVID Conditions Among Adult COVID-19 Survivors Aged 18\u201364 and \u226565 Years \u2014 United States, March 2020\u2013 November 2021. Available at: https:\/\/www.cdc.gov\/mmwr\/volumes\/71\/wr\/mm7121e1.htm. Accessed 31 October 2022.","DOI":"10.15585\/mmwr.mm7121e1"},{"key":"2023021811200605000_2023.02.13.23285855v1.7","doi-asserted-by":"crossref","unstructured":"Tenforde MW , Devine OJ , Reese HE , et al. Point Prevalence Estimates of Activity-Limiting Long-Term Symptoms among U.S. Adults >\/=1 Month After Reported SARS-CoV-2 Infection, November 1, 2021. J Infect Dis 2022.","DOI":"10.1093\/infdis\/jiac281"},{"issue":"9","key":"2023021811200605000_2023.02.13.23285855v1.8","doi-asserted-by":"crossref","first-page":"e2127403","DOI":"10.1001\/jamanetworkopen.2021.27403","article-title":"Symptoms and Health Outcomes Among Survivors of COVID-19 Infection 1 Year After Discharge From Hospitals in Wuhan, China","volume":"4","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"7","key":"2023021811200605000_2023.02.13.23285855v1.9","doi-asserted-by":"crossref","first-page":"969","DOI":"10.7326\/M21-4905","article-title":"A Longitudinal Study of COVID-19 Sequelae and Immunity: Baseline Findings","volume":"175","year":"2022","journal-title":"Ann Intern Med"},{"key":"2023021811200605000_2023.02.13.23285855v1.10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n693"},{"issue":"7","key":"2023021811200605000_2023.02.13.23285855v1.11","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/jama.2022.11691","article-title":"Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers","volume":"328","year":"2022","journal-title":"JAMA"},{"key":"2023021811200605000_2023.02.13.23285855v1.12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-069676"},{"key":"2023021811200605000_2023.02.13.23285855v1.13","doi-asserted-by":"crossref","unstructured":"Xie Y , Choi T , Al-Aly Z. Nirmatrelvir and the Risk of Post-Acute Sequelae of COVID-19. medRxiv 2022: 2022.11.03.22281783 [Preprint] [cited 2023 Feb 11]. Available from: https:\/\/www.medrxiv.org\/content\/10.1101\/2022.11.03.v1.","DOI":"10.1101\/2022.11.03.22281783"},{"key":"2023021811200605000_2023.02.13.23285855v1.14","doi-asserted-by":"publisher","DOI":"10.1038\/S41591-020-1051-9"},{"key":"2023021811200605000_2023.02.13.23285855v1.15","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-020-00798-x"},{"key":"2023021811200605000_2023.02.13.23285855v1.16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0242400"},{"key":"2023021811200605000_2023.02.13.23285855v1.17","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1038-6"},{"issue":"1","key":"2023021811200605000_2023.02.13.23285855v1.18","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1080\/22221751.2020.1770129","article-title":"Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors","volume":"9","year":"2020","journal-title":"Emerg Microbes Infect"},{"issue":"9","key":"2023021811200605000_2023.02.13.23285855v1.19","doi-asserted-by":"crossref","first-page":"ofab448","DOI":"10.1093\/ofid\/ofab448","article-title":"Sex and Gender Differences in Testing, Hospital Admission, Clinical Presentation, and Drivers of Severe Outcomes From COVID-19","volume":"8","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2023021811200605000_2023.02.13.23285855v1.20","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab490"},{"key":"2023021811200605000_2023.02.13.23285855v1.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109518"},{"key":"2023021811200605000_2023.02.13.23285855v1.22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010359"},{"key":"2023021811200605000_2023.02.13.23285855v1.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.01.014"},{"key":"2023021811200605000_2023.02.13.23285855v1.24","doi-asserted-by":"crossref","first-page":"922422","DOI":"10.3389\/fcimb.2022.922422","article-title":"Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome","volume":"12","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"2023021811200605000_2023.02.13.23285855v1.25","doi-asserted-by":"crossref","unstructured":"Swank Z , Senussi Y , Manickas-Hill Z , et al. Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae. Clin Infect Dis 2022.","DOI":"10.1101\/2022.06.14.22276401"},{"key":"2023021811200605000_2023.02.13.23285855v1.26","doi-asserted-by":"crossref","unstructured":"Durstenfeld MS , Peluso MJ , Kaveti P , et al. Inflammation during early post-acute COVID-19 is associated with reduced exercise capacity and Long COVID symptoms after 1 year. medRxiv 2022.","DOI":"10.1101\/2022.05.17.22275235"},{"issue":"18","key":"2023021811200605000_2023.02.13.23285855v1.27","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1056\/NEJMoa2119657","article-title":"Early Outpatient Treatment for Covid-19 with Convalescent Plasma","volume":"386","year":"2022","journal-title":"N Engl J Med"},{"issue":"51","key":"2023021811200605000_2023.02.13.23285855v1.28","doi-asserted-by":"crossref","first-page":"7176","DOI":"10.1016\/j.vaccine.2015.10.134","article-title":"Baseline serum interleukin-6 to interleukin-2 ratio is associated with the response to seasonal trivalent influenza vaccine in solid organ transplant recipients","volume":"33","year":"2015","journal-title":"Vaccine"},{"key":"2023021811200605000_2023.02.13.23285855v1.29","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa574"},{"issue":"4","key":"2023021811200605000_2023.02.13.23285855v1.30","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/TP.0000000000004057","article-title":"Higher Proinflammatory Cytokines Are Associated With Increased Antibody Titer After a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients","volume":"106","year":"2022","journal-title":"Transplantation"},{"key":"2023021811200605000_2023.02.13.23285855v1.31","doi-asserted-by":"crossref","unstructured":"Vimercati L , De Maria L , Quarato M , et al. Association between Long COVID and Overweight\/Obesity. J Clin Med 2021; 10(18).","DOI":"10.3390\/jcm10184143"},{"key":"2023021811200605000_2023.02.13.23285855v1.32","doi-asserted-by":"crossref","unstructured":"Korper S , Gruner B , Zickler D , et al. One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients. J Clin Invest 2022.","DOI":"10.1172\/JCI163657"},{"issue":"6","key":"2023021811200605000_2023.02.13.23285855v1.33","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1172\/JCI138745","article-title":"Deployment of convalescent plasma for the prevention and treatment of COVID-19","volume":"130","year":"2020","journal-title":"J Clin Invest"},{"key":"2023021811200605000_2023.02.13.23285855v1.34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2031893"},{"issue":"9","key":"2023021811200605000_2023.02.13.23285855v1.35","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.7326\/M22-1079","article-title":"Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma","volume":"175","year":"2022","journal-title":"Ann Intern Med"},{"issue":"12","key":"2023021811200605000_2023.02.13.23285855v1.36","doi-asserted-by":"crossref","first-page":"e1003872","DOI":"10.1371\/journal.pmed.1003872","article-title":"Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study","volume":"18","year":"2021","journal-title":"PLoS Med"},{"issue":"3","key":"2023021811200605000_2023.02.13.23285855v1.37","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1182\/blood.2021012248","article-title":"COVID-19 convalescent plasma","volume":"140","year":"2022","journal-title":"Blood"},{"issue":"1","key":"2023021811200605000_2023.02.13.23285855v1.38","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ajpath.2020.10.008","article-title":"Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgG","volume":"191","year":"2021","journal-title":"Am J Pathol"},{"issue":"4","key":"2023021811200605000_2023.02.13.23285855v1.39","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1172\/JCI138003","article-title":"The convalescent sera option for containing COVID-19","volume":"130","year":"2020","journal-title":"J Clin Invest"},{"key":"2023021811200605000_2023.02.13.23285855v1.40","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0066-7"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2023.02.13.23285855","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T19:27:03Z","timestamp":1768505223000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2023.02.13.23285855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":40,"URL":"https:\/\/doi.org\/10.1101\/2023.02.13.23285855","relation":{},"subject":[],"published":{"date-parts":[[2023,2,16]]},"subtype":"preprint"}}